Rs 117.5 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Vogliboz GM 3 mg Tablets are formulated to provide effective relief from symptoms associated with vestibular disorders and Meniere's disease. Each tablet contains a combination of 3 mg of Betahistine dihydrochloride and 80 mg of Ginkgo Biloba extract. Betahistine works by enhancing blood flow to the inner ear, which helps to stabilize inner ear pressure and alleviate symptoms such as dizziness, vertigo, and tinnitus. Ginkgo Biloba adds further benefit by supporting cognitive function and improving peripheral blood circulation. This dual-action formula ensures a comprehensive approach to symptom management. The tablets are designed for convenience, with an easy-to-swallow form that allows for accurate dosing. Packaged in a 10-tablet bottle, Vogliboz GM 3 mg is suitable for both short-term symptom relief and ongoing management, contributing to improved quality of life by addressing the underlying causes of vestibular symptoms.
Active Ingredients: Each tablet contains 3 mg of Betahistine dihydrochloride and 80 mg of Ginkgo Biloba extract. Dual Action Formula: Combines Betahistine, which improves inner ear circulation to alleviate symptoms like dizziness and vertigo, with Ginkgo Biloba, known for enhancing cognitive function and peripheral circulation. Effective Symptom Relief: Designed to manage symptoms of vestibular disorders and Meniere's disease, including dizziness, vertigo, and tinnitus. Convenient Tablet Form: Comes in an easy-to-swallow tablet form, ensuring precise dosing and ease of use. 10-Tablet Pack: Available in a pack of 10 tablets, suitable for both short-term and long-term use.
VOGLIBOZ GM3 TABLET helps manage type 2 diabetes mellitus through a combination of three active ingredients. Glimepiride reduces blood glucose levels by stimulating the pancreas to release more insulin. Metformin lowers glucose levels by decreasing production of glucose in the liver and reducing glucose absorption in the stomach and intestines, while also enhancing the body's response to insulin. Voglibose inhibits the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simpler sugars, thereby slowing carbohydrate digestion and absorption in the small intestine. This combined effect leads to a reduction in blood glucose levels in individuals with type 2 diabetes mellitus.
Take VOGLIBOZ GM3 TABLET as directed by your physician. Swallow the tablet with a glass of water. Do not crush or chew the tablet. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
PREGNANCY CONTRAINDICATED:VOGLIBOZ GM3 TABLET is not recommended during pregnancy as it may harm the fetus. Consult your doctor before using VOGLIBOZ GM3 TABLET. BREASTFEEDING CONTRAINDICATED:VOGLIBOZ GM3 TABLET is not recommended for breastfeeding women as it may pass into breast milk and could harm the nursing child. Consult your doctor before using VOGLIBOZ GM3 TABLET. DRIVING AND USING MACHINES USE WITH CAUTION:Avoid driving or operating machinery if you experience impaired alertness or reactions due to hypoglycemia while taking VOGLIBOZ GM3 TABLET. ALCOHOL CONSULT YOUR DOCTOR:Avoid consuming alcohol while taking VOGLIBOZ GM3 TABLET as it may lower your blood sugar levels. Consult your doctor for advice. KIDNEY CONSULT YOUR DOCTOR:VOGLIBOZ GM3 TABLET is not recommended for patients with severe renal failure and should be used with caution in those with other kidney conditions. Consult your doctor before taking the medication. LIVER CONSULT YOUR DOCTOR:VOGLIBOZ GM3 TABLET is not recommended for patients with severe liver disease and should be used cautiously in those with other liver conditions. Consult your doctor before using VOGLIBOZ GM3 TABLET. ALLERGY CONTRAINDICATED:Do not take VOGLIBOZ GM3 TABLET if you are allergic to glimepiride, metformin, voglibose, sulfonylureas/sulphonamides, or any other components of this medication. LUNGS CONTRAINDICATED:VOGLIBOZ GM3 TABLET is not recommended for patients with lung issues such as acute or chronic respiratory failure. Consult your doctor before using VOGLIBOZ GM3 TABLET. HEART DISEASE CONTRAINDICATED:VOGLIBOZ GM3 TABLET is not recommended for patients with heart conditions like acute or chronic cardiac failure or recent myocardial infarction. Consult your doctor before using VOGLIBOZ GM3 TABLET. USE IN PEDIATRICS CONTRAINDICATED:VOGLIBOZ GM3 TABLET is not recommended for children and adolescents under 18 years due to a lack of established safety and effectiveness. Consult your doctor before giving VOGLIBOZ GM3 TABLET to younger patients. USE IN GERIATRICS USE WITH CAUTION:VOGLIBOZ GM3 TABLET should be used cautiously in elderly patients (65 years and older). Consult your doctor before using VOGLIBOZ GM3 TABLET.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s